Table 5.
Clinicopathological features of six tumors with HER2 mutations among 349 non‐small cell lung carcinomas
| Sample | Histology | Sex | Age (years) | Smoking (pack‐years) | P‐stage | Nucleotide change | Amino acid change |
|---|---|---|---|---|---|---|---|
| KD318 | Ad | F | 68 | 0 | IA | 2325–2336 ins ATACGTGATGGC | YVMA 776–779 ins |
| KD583 | Ad | F | 36 | 2 | IIIA | 2337–2339 ins TGT | G776V C ins |
| KD617 | Ad | M | 60 | 4 | IB | 2325–2336 ins ATACGTGATGGC | YVMA 776–779 ins |
| KD1007 | Ad | F | 54 | 0 | IA | 2325–2336 ins ATACGTGATGGC | YVMA 776–779 ins |
| KD1024 | Ad | F | 71 | 0 | IB | 2337–2339 ins TGG | G776V C ins |
| KD1027 | Ad | M | 67 | 45 | IIA | 2325–2336 ins ATACGTGATGGC | YVMA 776–779 ins |
Ad, adenocarcinoma; F, female; ins, insertion; M, male.